BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Heart
,
Laryngoscope
,
Cisplatin
,
rs6983267
,
DRD2
,
calcium channel activity
,
Hepatitis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hodgkin disease
Summary
General Info
Curated Studies
Most Correlated Studies
Cancer Gene Census - mutations in cancer genes
GSK cancer cell line transcript profiling
T-cell/histiocyte rich B cell (TCHRBCL) and nodular lymphocyte predominant Hodgkin lymphomas
Lymphocyte predominant Hodgkin lymphoma and its relationship to other lymphomas
Nodular lymphocyte predominant Hodgkin's lymphoma vs T cell/histiocyte rich B cell lymphoma
Explore Curated Studies Results
Literature
Most Relevant Literature
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNO…
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Con…
Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled …
Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's …
HL-305 Outcomes of Hodgkin Disease in Elderly Patients: Experience of the Hematology Department of C…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Mantle Irradiation for Hodgkin's Disease
Breast-Sparing Proton Therapy for Hodgkin's Disease
Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease
Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation
Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ